Patent directory · USPTO A61K / A61P
Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”
783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9511075
Targeting NCCA-ATP channel for organ protection following ischemic episode
granted -
US 9506041
Delivery of packaged RNA to mammalian cells
granted -
US 9498526
Human rotavirus vaccine strains and diagnostics
granted -
US 9492564
Dual specific immunotoxin for brain tumor therapy
granted -
US 9486518
Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine
granted -
US 9474793
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus
granted -
US 9458086
Compositions and methods for adipocyte modulation
granted -
US 9458215
Compositions and methods for osteogenic gene therapy
granted -
US 9439935
Recombinant rift valley fever (RVF) viruses and methods
granted -
US 9435000
Primate T-lymphotropic viruses
granted -
US 9421250
Pathogenic phlebovirus isolates and compositions and methods of use
granted -
US 9415099
Method of altering the immundominance hierarchy of HIV gag by DNA vaccine expressing conserved regions
granted -
US 9403872
Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors
granted -
US 9387224
Treatment of specific cardiovascular conditions with nitrite
granted -
US 9388221
Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies
granted -
US 9382302
Lutzomyia longipalpis polypeptides and methods of use
granted -
US 9375438
Inhibitors of NCCa-ATP channels for therapy
granted -
US 9375424
Compounds that treat malaria and prevent malaria transmission
granted -
US 9365626
Simukunin
granted -
US 9358306
Photosensitizing antibody-fluorophore conjugates
granted -
US 9353117
Substituted pyrazolopyrimidines as glucocerebrosidase activators
granted -
US 9347951
Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region
granted -
US 9345758
Materials and methods for respiratory disease control in canines
granted -
US 9346875
Therapy for filovirus infection
granted